Am J Clin Oncol 2018 Jun
Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors: A Retrospective Case Series Evaluating Clinical Outcomes, Toxicity, and Technical Considerations.   

Related Questions

Assume patient has normal renal function, is not a surgical candidate, and kidney is the only site of disease.